Xenon Pharmaceuticals Inc. (XENE) has 3 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $1.1M. Most recent filing: Sept. 3, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 3, 2026 filed Sept. 1, 2026 | Svoronos Dawn Director | $41,924 | 10,288 | — | No | |
|
|
||||||
| Aug. 31, 2026 filed Aug. 28, 2026 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | −$425,829 | 7,068 | −100% | Yes | |
|
|
||||||
| Aug. 13, 2026 filed Aug. 11, 2026 | GANNON STEVEN Director | −$640,550 | 10,000 | −84% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free